Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early detection of lung cancer.
Get this delivered to your inbox, and more info about our products and services.
Microsoft could stage a comeback as the technology firm's AI push starts to show signs of paying off, several analysts said.
Just as anything peripherally involved with the data center is blessed, anything even tangentially associated with pharma is a…
Health care is going to resume its rightful place in big-time managers' portfolios.
Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.
Wall Street analysts applauded the new Apple-Alphabet deal as one that would bolster the investment case for both companies.
Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
